Citi Maintains Establishment Labs(ESTA.US) With Hold Rating, Cuts Target Price to $45
Establishment Labs Holdings: A Cautious Hold Amid FDA Approval Process and High Short Interest
Establishment Labs Price Target Maintained With a $68.00/Share by Stephens & Co.
Establishment Labs Hldgs Analyst Ratings
Establishment Labs Holdings Poised for U.S. Market Entry: A Buy Rating Analysis
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Establishment Labs Hldgs Analyst Ratings
Establishment Labs Hldgs Analyst Ratings
Citi Upgrades Edwards, Tandem; Cuts Nevro, Establishment Labs
Establishment Labs Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Cytokinetics (CYTK)
Establishment Labs Hldgs Analyst Ratings
Citigroup Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $60
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
Establishment Labs Hldgs Analyst Ratings
Establishment Labs Hldgs Analyst Ratings
Buy Rating Affirmed for Establishment Labs on Positive FDA Approval Progress and Strong GMP Preparedness
Establishment Labs Hldgs Analyst Ratings
Establishment Labs Holdings: A Promising Buy Rating With Strategic Growth and Market Expansion